- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immunitybio Inc (IBRX)
Immunitybio Inc stock price live, this page displays NASDAQ IBRX stock exchange data. View the IBRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immunitybio Inc real time stock price chart below.
What Is the Immunitybio Inc Stock Price Today?
The Immunitybio Inc stock price today is 7.78.
What Is the Stock Symbol for Immunitybio Inc?
The stock ticker symbol for Immunitybio Inc is IBRX.
Is IBRX the Same as $IBRX?
$IBRX is a common way to refer to the Immunitybio Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Immunitybio Inc Trade On?
Immunitybio Inc is listed and trades on the NASDAQ stock exchange.
Is Immunitybio Inc a Good Stock to Buy?
Determining whether Immunitybio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Immunitybio Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IBRX quote. (ISIN: US45256X1037)
What Is the Immunitybio Inc Stock Price Today?
The Immunitybio Inc stock price today is 7.78.
What Is the Stock Symbol for Immunitybio Inc?
The stock ticker symbol for Immunitybio Inc is IBRX.
Is IBRX the Same as $IBRX?
$IBRX is a common way to refer to the Immunitybio Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Immunitybio Inc Trade On?
Immunitybio Inc is listed and trades on the NASDAQ stock exchange.
Is Immunitybio Inc a Good Stock to Buy?
Determining whether Immunitybio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Immunitybio Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IBRX quote. (ISIN: US45256X1037)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.36
7.81
52 wk Range
1.83
12.43
IBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.367.81
52 wk Range
1.8312.43
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IBRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
14.80
Upside
+90.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 8K Immunitybio Inc For: 9 April
- Investing.com
- Form 8K Immunitybio Inc For: 9 April
- Investing.com
- Form 8K Immunitybio Inc For: 6 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company’s platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.
Immunitybio Inc Earnings Call Summary for Q4/2025
- Q4 2025 EPS of -$0.06 beat forecast of -$0.11; revenue hit $38.28M, exceeding $35.99M estimate by 6.36%
- Stock surged 32.76% to $11.55 in pre-market trading; full-year revenue jumped 700% to $113M driven by ANKTIVA adoption
- Net loss reduced 15% year-over-year to $351.4M; sequential quarterly growth demonstrated strong commercial momentum
- 2026 guidance projects EPS of -$0.07 per quarter; revenue forecasts show $51.36M for Q2 and $60.01M for Q3
- CEO emphasized transformational progress with ANKTIVA's FDA approval and international expansion plans underway
Last Updated: 03/03/2026, 06:38 PM
Read Full TranscriptCompare IBRX to Peers and Sector
Metrics to compare | IBRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIBRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.3x | −1.5x | −0.5x | |
PEG Ratio | −0.58 | −0.09 | 0.00 | |
Price / Book | −15.7x | 2.4x | 2.6x | |
Price / LTM Sales | 69.3x | 5.8x | 3.2x | |
Upside (Analyst Target) | 71.1% | 113.7% | 47.6% | |
Fair Value Upside | Unlock | 14.8% | 6.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.80
(+90.23% Upside)
Earnings
Latest Release
Feb 23, 2026
EPS / Forecast
-0.06 / -0.11
Revenue / Forecast
38.28M / 35.99M
People Also Watch
FAQ
What Is the Immunitybio Inc (IBRX) Stock Price Today?
The Immunitybio Inc stock price today is 7.78 USD.
What Stock Exchange Does Immunitybio Inc Trade On?
Immunitybio Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Immunitybio Inc?
The stock symbol for Immunitybio Inc is "IBRX."
What Is the Immunitybio Inc Market Cap?
As of today, Immunitybio Inc market cap is 7.95B USD.
What Is Immunitybio Inc's Earnings Per Share (TTM)?
The Immunitybio Inc EPS (TTM) is -0.38.
When Is the Next Immunitybio Inc Earnings Date?
Immunitybio Inc will release its next earnings report on May 07, 2026.
From a Technical Analysis Perspective, Is IBRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Immunitybio Inc Stock Split?
Immunitybio Inc has split 0 times.
How Many Employees Does Immunitybio Inc Have?
Immunitybio Inc has 688 employees.
What is the current trading status of Immunitybio Inc (IBRX)?
As of Apr 15, 2026, Immunitybio Inc (IBRX) is trading at a price of 7.78 USD, with a previous close of 7.60 USD. The stock has fluctuated within a day range of 7.36 USD to 7.81 USD, while its 52-week range spans from 1.83 USD to 12.43 USD.
What Is Immunitybio Inc (IBRX) Price Target According to Analysts?
The average 12-month price target for Immunitybio Inc is 14.80 USD, with a high estimate of 23 USD and a low estimate of 11 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +90.23% Upside potential.
What Is the IBRX Premarket Price?
IBRX's last pre-market stock price is 7.52 USD. The pre-market share volume is 161,190.00, and the stock has decreased by -0.08, or -1.05%.
What Is the IBRX After Hours Price?
IBRX's last after hours stock price is 7.73 USD, the stock has decreased by -0.05, or -0.64%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.